○Shinji Aoyama¹, Daisuke Sato¹, Akira Tubouchi¹, Akio Saito¹ (1. Grad. Eng., Tokyo Univ. Agric. Tech.)

○Daiki Kuwana¹, Masanori Nagatomo¹, Masayuki Inoue¹ (1. Grad. Sch. Pharm. Sci., The Univ. of Tokyo)

○Saki Maejima¹, Eiji Yamaguchi¹, Akichika Itoh¹ (1. Gifu Pharm. Univ.)

○Kohta Ide¹, Miyu Furuta¹, Hidetoshi Tokuyama¹ (1. Grad. Sch. Pharm. Sci., Tohoku Univ.)

○Hiroyasu Nakao¹, Hiromu Fuse¹, Yutaka Saga², Arisa Fukatsu³, Mio Kondo², Shigeyuki Masaoka², Harunobu Mitsunuma¹, Motomu Kanai¹ (1. Graduate School of Pharmaceutical Sciences, The University of Tokyo, 2. Graduate School of Engineering, Osaka University, 3. Department of Life and Coordination-Complex Molecular Science, Institute for Molecular Science (IMS))

○Daiki Ishii¹, Shin-ichi Hirashima¹, Kosuke Nakashima¹, Hiroshi Akutsu², Takaaki Sakai³, Yasuyuki Matsushima¹, Masahiro Kawada¹, Tsuyoshi Miura¹ (1. Pharm., Tokyo Univ. of Pharm. and Life Sci., 2. Fac. Pharm. & Phamceu. Sci., Josai Univ., 3. Pharm. at Fukuoka, International Univ. of Health and Welfare)